Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017
- PMID: 29495923
- DOI: 10.1080/23744235.2018.1445281
Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017
Abstract
Aim: Following the approval of two new therapeutic combinations within the European Union in 2017, the former Swedish recommendations for the treatment of hepatitis C virus (HCV) infection from 2016 were deemed in need of updating.
Materials and methods: An expert meeting to this end was held in Stockholm, Sweden in October 2017.
Results and conclusions: An interferon-free combination of direct-acting antiviral agents is now recommended for all patients with chronic HCV infection, regardless of liver fibrosis stage, in order to limit morbidity and spread of the disease. An extended discussion of treatment for people who inject drugs in order to diminish transmission is included.
Keywords: Children; Chronic kidney disease; Direct-acting antiviral agents; Elimination; Eradication; Genotype; Guidelines; HCV; HIV; Hepatitis C virus; PWIDs; People who inject drugs; Resistance associated substitutions (RASs); Resistance associated variants (RAVs); Ribavirin.
Similar articles
-
Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.Infect Dis (Lond). 2017 Aug;49(8):561-575. doi: 10.1080/23744235.2017.1300682. Epub 2017 Mar 15. Infect Dis (Lond). 2017. PMID: 28293974 Review.
-
Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.Infect Dis (Lond). 2016 Apr;48(4):251-261. doi: 10.3109/23744235.2015.1113438. Epub 2015 Dec 1. Infect Dis (Lond). 2016. PMID: 26624849 Free PMC article. Review.
-
Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.Scand J Infect Dis. 2009;41(6-7):389-402. doi: 10.1080/00365540902998271. Scand J Infect Dis. 2009. PMID: 20001276 Review.
-
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.Pharmacotherapy. 2016 Feb;36(2):203-17. doi: 10.1002/phar.1700. Epub 2016 Feb 5. Pharmacotherapy. 2016. PMID: 26846728 Review.
-
[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3].Korean J Gastroenterol. 2016 Mar;67(3):132-6. doi: 10.4166/kjg.2016.67.3.132. Korean J Gastroenterol. 2016. PMID: 26996182 Review. Korean.
Cited by
-
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017.Subst Abuse Treat Prev Policy. 2020 Jun 30;15(1):44. doi: 10.1186/s13011-020-00286-2. Subst Abuse Treat Prev Policy. 2020. PMID: 32605625 Free PMC article.
-
Hepatitis C virus infection in children in the era of direct-acting antiviral.World J Gastroenterol. 2018 Jun 28;24(24):2555-2566. doi: 10.3748/wjg.v24.i24.2555. World J Gastroenterol. 2018. PMID: 29962813 Free PMC article. Review.
-
The impact of treatment on the psychological burden of mothers of children with chronic hepatitis C virus infection: a multicenter, questionnaire survey.Sci Rep. 2022 Dec 21;12(1):22116. doi: 10.1038/s41598-022-25519-1. Sci Rep. 2022. PMID: 36543833 Free PMC article.
-
Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden.Harm Reduct J. 2023 Jun 16;20(1):77. doi: 10.1186/s12954-023-00806-w. Harm Reduct J. 2023. PMID: 37328868 Free PMC article.
-
Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection.Intern Med. 2020 Apr 1;59(7):941-944. doi: 10.2169/internalmedicine.3824-19. Epub 2019 Dec 6. Intern Med. 2020. PMID: 31813916 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
